GE HealthCare (GEHC) PT Raised to $104 at Stifel

GE HealthCare (GEHC) PT Raised to $110 at Jefferies

Jefferies analyst Matthew Taylor raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.

The analyst comments "GEHC reported 4Q sales of $5.32B, +2% xfx (+4% ex-China) vs cons $5.32B, & EPS of $1.45 +23% vs cons $1.26. Orders... More

GE HealthCare (GEHC) PT Raised to $110 at Citi

Citi analyst Joanne Wuensch raised the price target on GE HealthCare (NASDAQ: GEHC) to $110.00 (from $103.00) while maintaining a Buy rating.

The analyst comments "There was a lot to the 4Q24 against relatively low expectations, with the top-line reflecting continued pressures in China, and... More

GE HealthCare (GEHC) PT Raised to $103 at BTIG

BTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $103.00 (from $99.00) while maintaining a Buy rating.

The analyst comments "We maintain our Buy and raise our PT to $103 (from $99) following GEHC's 4Q24 results. Rev. of $5.319B (2.0% Y/Y, 2.0% Y/Y organic) and adj. EPS of $1.45 (22.9% Y/Y)... More

GE HealthCare forecasts upbeat 2025 profit on steady medical device demand

(Reuters) - GE HealthCare Technologies on Thursday forecast annual profit above Wall Street estimates, counting on strong demand for its medical devices in markets such as the U.S. to offset weakness in China.

Manufacturers of medical devices have been benefiting from elevated demand for elective surgical procedures in the United States, especially among older adults. German peer Siemens... More

GE HealthCare tops Q4 profit estimates, offers full-year guidance

GE HealthCare Technologies Inc (NASDAQ: GEHC) posted better-than-expected earnings and adjusted EBIT for the fourth quarter, while revenue marginally missed expectations.

The health technology company reported Q4 earnings per share (EPS) of $1.45, surpassing consensus estimates of $1.26. The company's revenue rose 2% year-over-year to $5.32... More

GE HealthCare (GEHC) Tops Q4 EPS by 19c; offers outlook

GE HealthCare (NASDAQ: GEHC) reported Q4 EPS of $1.45, $0.19 better than the analyst estimate of $1.26. Revenue for the quarter came in at $5.32 billion versus the consensus estimate of $5.33 billion.

GUIDANCE:

GE HealthCare sees FY2025 EPS of $4.61-$4.75, versus the consensus of... More

GE HealthCare (GEHC) call put ratio 1.8 calls to 1 put into quarter results

GE HealthCare (NASDAQ: GEHC) February 14 weekly call option implied volatility is at 94, February is at 48; compared to its 52-week range of 18 to 42 into the expected release of quarter results before the bell on February 13.

GE HealthCare (GEHC) February 14 weekly 87 straddle priced into quarter results

GE HealthCare (NASDAQ: GEHC) February 14 weekly 87 straddle priced for movement of 7% into the expected release of quarter results before the bell on February 13.